These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29540456)

  • 1. Role of Disputed Mutations in the
    Miotto P; Cabibbe AM; Borroni E; Degano M; Cirillo DM
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29540456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.
    Torrea G; Ng KCS; Van Deun A; André E; Kaisergruber J; Ssengooba W; Desmaretz C; Gabriels S; Driesen M; Diels M; Asnong S; Fissette K; Gumusboga M; Rigouts L; Affolabi D; Joloba M; De Jong BC
    Sci Rep; 2019 Aug; 9(1):11826. PubMed ID: 31413308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.
    Yoo IY; Huh HJ; Kang OK; Jhun BW; Koh WJ; Lee NY
    Respir Med; 2019 Jan; 146():71-75. PubMed ID: 30665521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.
    Ocheretina O; Escuyer VE; Mabou MM; Royal-Mardi G; Collins S; Vilbrun SC; Pape JW; Fitzgerald DW
    PLoS One; 2014; 9(3):e90569. PubMed ID: 24599230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
    Rigouts L; Gumusboga M; de Rijk WB; Nduwamahoro E; Uwizeye C; de Jong B; Van Deun A
    J Clin Microbiol; 2013 Aug; 51(8):2641-5. PubMed ID: 23761146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai.
    Ahmad S; Mokaddas E; Fares E
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):245-52. PubMed ID: 12493171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
    Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
    Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.
    Yu HJ; Kim TY; Kim G; Shim HJ; Kang OK; Kim S; Kim CK; Jhun BW; Lee NY; Huh HJ; Lee HJ
    J Clin Microbiol; 2023 Jan; 61(1):e0108622. PubMed ID: 36602360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillance.
    Gonzalo X; Claxton P; Brown T; Montgomery L; Fitzgibbon M; Laurenson I; Drobniewski F
    Clin Microbiol Infect; 2017 Apr; 23(4):260-263. PubMed ID: 27903459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disputed
    Lin WH; Lee WT; Tsai HY; Jou R
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0157320. PubMed ID: 33846134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
    Jamieson FB; Guthrie JL; Neemuchwala A; Lastovetska O; Melano RG; Mehaffy C
    J Clin Microbiol; 2014 Jun; 52(6):2157-62. PubMed ID: 24740074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Analysis of False-Positive and Disputed Rifampin Resistance Xpert MTB/RIF Assay Results in Clinical Samples from a Referral Hospital in Hunan, China.
    Hu P; Zhang H; Fleming J; Zhu G; Zhang S; Wang Y; Liu F; Yi S; Chen Z; Chen Z; Liu B; Gong D; Wan L; Wang X; Tan Y; Bai L; Bi L
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30674578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Level Rifampin Resistance and
    Shea J; Halse TA; Kohlerschmidt D; Lapierre P; Modestil HA; Kearns CH; Dworkin FF; Rakeman JL; Escuyer V; Musser KA
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 32999007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City.
    Cooksey RC; Morlock GP; Glickman S; Crawford JT
    J Clin Microbiol; 1997 May; 35(5):1281-3. PubMed ID: 9114427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.
    Somoskovi A; Song Q; Mester J; Tanner C; Hale YM; Parsons LM; Salfinger M
    J Clin Microbiol; 2003 Jul; 41(7):2822-6. PubMed ID: 12843007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
    McCammon MT; Gillette JS; Thomas DP; Ramaswamy SV; Graviss EA; Kreiswirth BN; Vijg J; Quitugua TN
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2200-9. PubMed ID: 15917513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.
    Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM
    Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.